Literature DB >> 26815458

[Boston-keratoprosthesis : Preliminary experiences in 13 high-risk eyes from the Department of Ophthalmology of the University of Cologne].

F Schaub1, D Hos2, F Bucher2, S Siebelmann2, B O Bachmann2, C Cursiefen2.   

Abstract

BACKGROUND: Corneal transplantation in high-risk eyes remains a challenge. The Boston keratoprosthesis (B-KPro) is a final option for patients with end-stage corneal disease and a poor prognosis with conventional penetrating keratoplasty. In this article the results of the first 13 eyes that received a B-KPro type I at the Department of Ophthalmology, University of Cologne, Germany are reported and the usefulness of postoperative slit-lamp optical coherence tomography (SL-OCT) for control purposes is evaluated.
MATERIAL AND METHODS: All recipients of a B-KPro type I between September 2013 and May 2015 were included in the study. The feasibility of the operation, clinical outcomes, complications and revision surgery were investigated. The visualization of wound healing by SL-OCT was analyzed.
RESULTS: The age of the patients ranged from 26 to 92 years (mean 57.3 ± 20.9 years). In all 13 eyes from 12 patients (6 males and 6 females) dense corneal opacification with vascularization and sometimes also conjunctivalization was present. Preoperative visual acuity was reduced and ranged from mere light perception up to a maximum of 1/35 eye chart. All 13 eyes could be supplied with a B-KPro type I without any intraoperative complications, in 6 eyes no significant postoperative complications occurred, whereas in 7 eyes various additional surgical interventions were required and 1 B-KPro could not be preserved. Postoperative visual acuity ranged from light perception to 20/32 and was significantly improved in 85 % of the treated eyes. The use of SL-OCT reproducibly allowed the postoperative assessment of stromal thinning.
CONCLUSION: The B-KPro provides the possibility of visual rehabilitation in high-risk eyes that could never be achieved without artificial cornea replacement. Despite higher complication rates this technique represents a significant progress in the surgical treatment of complex corneal pathologies. Regular and intensive postoperative controls are necessary to achieve good long-term results.

Entities:  

Keywords:  Artificial cornea; Complications; Corneal diseases; Keratoplasty; Split lamp optical coherence tomography

Mesh:

Year:  2016        PMID: 26815458     DOI: 10.1007/s00347-015-0209-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  30 in total

1.  Protective effect of soft contact lenses after Boston keratoprosthesis.

Authors:  Leah L Kammerdiener; Jaime Lynn Speiser; James V Aquavella; Mona Harissi-Dagher; Claes H Dohlman; James Chodosh; Joseph B Ciolino
Journal:  Br J Ophthalmol       Date:  2015-08-14       Impact factor: 4.638

Review 2.  Endothelial keratoplasty: DSEK/DSAEK or DMEK--the thinner the better?

Authors:  Isabel Dapena; Lisanne Ham; Gerrit R J Melles
Journal:  Curr Opin Ophthalmol       Date:  2009-07       Impact factor: 3.761

3.  [Boston type I keratoprosthesis: review].

Authors:  Sérgio Kwitko
Journal:  Arq Bras Oftalmol       Date:  2012 Nov-Dec       Impact factor: 0.872

4.  Boston type 1 keratoprosthesis: the CHUM experience.

Authors:  Marie-Claude Robert; Mona Harissi-Dagher
Journal:  Can J Ophthalmol       Date:  2011-04       Impact factor: 1.882

5.  Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.

Authors:  Canan Asli Utine; Jonathan H Tzu; Esen K Akpek
Journal:  Ocul Immunol Inflamm       Date:  2011-12       Impact factor: 3.070

6.  Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.

Authors:  Mustafa Kosker; Kunal Suri; Christopher J Rapuano; Brandon D Ayres; Parveen K Nagra; Irving M Raber; Kristin M Hammersmith
Journal:  Cornea       Date:  2015-09       Impact factor: 2.651

7.  Retention of the Boston keratoprosthesis type 1: multicenter study results.

Authors:  Joseph B Ciolino; Michael W Belin; Amit Todani; Khalid Al-Arfaj; Christopher J Rudnisky
Journal:  Ophthalmology       Date:  2013-03-15       Impact factor: 12.079

8.  [Long-term outcomes of Boston keratoprosthesis].

Authors:  Yosai Mori; Ryohei Nejima; Keiichiro Minami; Kazunori Miyata; Kazutaka Kamiya; Masahiko Fukud
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2013-01

9.  Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1.

Authors:  Anastasios J Kanellopoulos; George Asimellis
Journal:  Cornea       Date:  2014-09       Impact factor: 2.651

10.  Ultra high resolution optical coherence tomography in Boston type I keratoprosthesis.

Authors:  Siamak Zarei-Ghanavati; Carolina Betancurt; Alma Michelle Mas; Jianhua Wang; Victor L Perez
Journal:  J Ophthalmic Vis Res       Date:  2015 Jan-Mar
View more
  4 in total

1.  [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].

Authors:  F Schaub; I Neuhann; P Enders; B O Bachmann; B Koller; T Neuhann; C Cursiefen
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

2.  [Corneal donation : Dilemma between growing demand and declining donor rate].

Authors:  F Schaub; H G Simons; P Enders; B O Bachmann; S Roters; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

Review 3.  [Boston type I keratoprosthesis implantation technique : Video article].

Authors:  M Matthaei; B Bachmann; D Hos; S Siebelmann; F Schaub; C Cursiefen
Journal:  Ophthalmologe       Date:  2019-01       Impact factor: 1.059

Review 4.  [Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].

Authors:  F Schaub; M Matthaei; P Enders; S Siebelmann; D Hos; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.